PASIREOTIDE DIASPARTATE for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where PASIREOTIDE DIASPARTATE was used for Off label use.
Most Reported Side Effects for PASIREOTIDE DIASPARTATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 66 | 23.3% | 1 | 16 |
| Off label use | 42 | 14.8% | 3 | 9 |
| Fatigue | 40 | 14.1% | 0 | 11 |
| Diarrhoea | 38 | 13.4% | 2 | 9 |
| Blood glucose increased | 36 | 12.7% | 1 | 7 |
| Diabetes mellitus | 35 | 12.4% | 0 | 4 |
| Dizziness | 34 | 12.0% | 0 | 5 |
| Vomiting | 34 | 12.0% | 0 | 12 |
| Headache | 33 | 11.7% | 1 | 8 |
| Hyperglycaemia | 20 | 7.1% | 0 | 5 |
| Hypoglycaemia | 19 | 6.7% | 0 | 7 |
| Abdominal pain | 18 | 6.4% | 0 | 7 |
| Asthenia | 17 | 6.0% | 0 | 7 |
| Blood glucose decreased | 16 | 5.7% | 0 | 4 |
| Blood pressure increased | 16 | 5.7% | 0 | 5 |
Other Indications for PASIREOTIDE DIASPARTATE
Pituitary-dependent cushing's syndrome (146)
Product used for unknown indication (38)
Cushing's syndrome (32)
Acromegaly (22)
Hypoglycaemia (20)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)